Aoibhinn McDonnell
Appearances
- DateMay 9, 2023BACKGROUND: After successful induction, a subset of patients with Crohn’s disease (CD) experience a secondary loss of response (LoR) to ustekinumab (UST) maintenance therapy. Dose intensification may assist in regaining response…
Presenter
Speakers
Icahn School of Medicine, Mount SinaiSwedish Medical CenterWestern UniversityKatholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven - DateMay 9, 2023BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…
Presenter
Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven